10/27/2020, 1:30 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Pfizer Inc

Pfizer: Emergency-use vaccine possibly in Nov.

While Pfizer states planning phase 2/3 study of coronavirus antiviral drug by early 2021, the firm claimed on Tuesday that there could be an emergency-use application of its COVID-19 vaccine in late November if the research shows positive results.

However, there is no interim efficiency analysis of the vaccine yet, as it has to be conducted by the Data Monitoring Committee prior to the submission of the request for an emergency-use authorization by the United States Food and Drug Administration (FDA).

While the pandemic-related numbers in the United States continue to go up, the necessity of a reliable vaccine becomes more and more urgent.

Breaking the News / CG